Practice patterns, attitudes, and knowledge among clinicians regarding hyperthermic intraperitoneal chemotherapy and pressurized intraperitoneal aerosol chemotherapy: a national survey by Indian society of peritoneal surface malignancies (ISPSM) [0.03%]
印度腹膜表面恶性肿瘤学会(ISPSM)关于高温腹腔内化学治疗和加压腹腔喷雾化疗的实践模式、态度和知识的全国调查
Sampige Prasanna Somashekhar,Kumar C Rohit,S V S Deo et al.
Sampige Prasanna Somashekhar et al.
Objectives: Perception of cytoreductive surgery (CRS), hyperthermic intraperitoneal chemotherapy (HIPEC), and pressurized intraperitoneal aerosol chemotherapy (PIPAC) for treating peritoneal surface malignancies (PSM) dif...
Dahbia Djelil,Anthony Dohan,Marc Pocard
Dahbia Djelil
Impact of insurance status on overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) [0.03%]
保险状况对细胞减灭术和腹腔热灌注化疗(CRS-HIPEC)后生存率影响的研究
Ravi J Chokshi,Jin K Kim,Jimmy Patel et al.
Ravi J Chokshi et al.
Objectives: The impact of insurance status on oncological outcome in patients undergoing cytoreduction and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is poorly understood. ...
Evaluation of delay in time to adjuvant chemotherapy after HIPEC and its impact on oncological outcome in advanced epithelial ovarian cancer [0.03%]
肿瘤细胞减灭术联合HIPEC术后辅助化疗延迟及对晚期卵巢癌患者预后影响的评估
S P Somashekhar,Y Ramya,K R Ashwin et al.
S P Somashekhar et al.
Obejectives: Optimal cytoreductive surgery (CRS), followed by adjuvant chemotherapy, is a major predictor of oncological outcome in patients with advanced epithelial ovarian carcinoma (EOC). It is not clear if a delayed s...
Visceral scalloping in pancreatic ascites: An uncommon manifestation of pancreatitis [0.03%]
胰腺腹水中的内脏切迹：胰腺炎的少见表现形式
Antriksh Kumar,Atul Rana,Anupam K Singh et al.
Antriksh Kumar et al.
Scalloping of visceral organs like liver and spleen can cause certain peritoneal diseases. It has usually been described with pseudomyxoma peritonei and peritoneal carcinomatosis. Occasionally, it has also been described with certain benign...
Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial [0.03%]
阿莫西林-克拉维酸治疗稳定型社区获得性复杂性包裹性脓肿两周与三周疗效的对比。一项初步的非劣效、双盲、随机对照试验
José M Porcel,Lucia Ferreiro,Laura Rumi et al.
José M Porcel et al.
Background: The optimal duration of antibiotic treatment for complicated parapneumonic effusions (CPPEs) has not been properly defined. Our aim was to compare the efficacy of amoxicillin-clavulanate for 2 vs. 3 weeks in p...
Postoperative paralytic ileus after cytoreductive surgery combined with heated intraperitoneal chemotherapy [0.03%]
细胞减灭术联合腹腔热灌注化疗后的术后麻痹性肠梗阻
Jesper Nors,Jonas Amstrup Funder,David Richard Swain et al.
Jesper Nors et al.
Background: Patients with peritoneal malignancy treated by cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) are prone to develop postoperative paralytic ileus (POI). POI is assoc...
The PEritoneal SUrface CAlculator (PESUCA): A new tool to quantify the resected peritoneal surface area after cytoreductive surgery [0.03%]
腹膜表面计算器(PESUCA)：量化细胞减灭术后切除的腹膜表面积的新工具
Philipp Schredl,Jan Philipp Ramspott,Daniel Neureiter et al.
Philipp Schredl et al.
Background: The body surface area (BSA) is taken as a measure for the effective contact area for dosing in hyperthermic intraperitoneal chemotherapy (HIPEC). Currently, the pharmacokinetic effect of the reduced peritoneal...
Survey on the current gynaecological approach of ovarian cancer patients: The utility of HIPEC [0.03%]
卵巢癌患者当前妇科治疗方法的调查研究：HIPEC的效用
Christos Iavazzo,Alexandros Fotiou,M Tsiatas et al.
Christos Iavazzo et al.
Background: The aim of this survey was to acquire an overview of the current management of ovarian cancer with an emphasis on the utility of hyperthermic intraperitoneal chemotherapy (HIPEC).Methods: An email was sent to ...
"Peritoneal failure": A new concept to explain negative results of randomized trials evaluating intraperitoneal therapies [0.03%]
"腹膜失效"——解释随机对照试验中评价腹腔治疗的阴性结果的新概念
Marc Pocard,Marc A Reymond
Marc Pocard